drugset / Trial / NCT03482167

NAD Therapy for Improving Memory and Brain Blood Flow in Older Adults With Mild Cognitive Impairment

NCT03482167

RandomizedParallel-groupDouble-blindTreatment

Summary

This study will provide insight into whether a nutritional supplement, nicotinamide riboside (NR), improves memory and brain blood flow in older adults with low memory abilities. Overall, this project has the potential to identify a novel, safe and cost-effective strategy for decreasing age-related memory loss.

Timeline

Start
2019-03-20
Primary completion
2024-01-08
Completion
2024-01-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Nicotinamide riboside Small molecule 500 mg